000 01634 a2200505 4500
005 20250513231022.0
264 0 _c20010405
008 200104s 0 0 eng d
022 _a1043-0342
024 7 _a10.1089/104303401750061258
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGordon, E M
245 0 0 _aSystemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice.
_h[electronic resource]
260 _bHuman gene therapy
_cJan 2001
300 _a193-204 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aCollagen
_xgenetics
650 0 4 _aCyclin G
650 0 4 _aCyclin G1
650 0 4 _aCyclins
_xgenetics
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aGenetic Vectors
650 0 4 _aHumans
650 0 4 _aIn Situ Nick-End Labeling
650 0 4 _aInfusions, Intravenous
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aRetroviridae
_xgenetics
650 0 4 _aSkin Neoplasms
_xmetabolism
650 0 4 _aTransplantation, Heterologous
650 0 4 _abeta-Galactosidase
_xmetabolism
700 1 _aChen, Z H
700 1 _aLiu, L
700 1 _aWhitley, M
700 1 _aLiu, L
700 1 _aWei, D
700 1 _aGroshen, S
700 1 _aHinton, D R
700 1 _aAnderson, W F
700 1 _aBeart, R W
700 1 _aHall, F L
773 0 _tHuman gene therapy
_gvol. 12
_gno. 2
_gp. 193-204
856 4 0 _uhttps://doi.org/10.1089/104303401750061258
_zAvailable from publisher's website
999 _c11116056
_d11116056